The Canadian Breakpoint
The Canadian Breakpoint
Dr. Rupeena Purewal
A review of Cabenuva®, an antiretroviral agent for HIV.
36 minutes Posted Feb 22, 2022 at 8:42 pm.
0:00
36:02
Download MP3
Show notes

Dr. Rupeena Purewal invites special guest Saskatoon pharmacist Carley Pozniak to review Cabenuva®, an antiretroviral agent for HIV. Cabenuva® (Cabotegravir Extended Release Injectable Suspension) has been approved in 2020 for medical use in Canada.